Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report.
IDCases
; 32: e01727, 2023.
Article
in English
| MEDLINE | ID: covidwho-2273305
ABSTRACT
Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Language:
English
Journal:
IDCases
Year:
2023
Document Type:
Article
Affiliation country:
J.idcr.2023.e01727
Similar
MEDLINE
...
LILACS
LIS